Stay updated on Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing v3.5.3. This indicates a minor platform update to the page.
    Difference
    0.0%
    Check dated 2026-05-17T08:41:10.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page’s displayed interface/version label has been updated from “v3.5.0” to “v3.5.3,” indicating a site revision rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-25T18:25:02.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and Revision: v3.4.3 removed in the study history. This is a minor version-tracking update and does not modify study data or page content.
    Difference
    0.0%
    Check dated 2026-03-20T19:48:26.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history log.
    Difference
    0.0%
    Check dated 2026-03-06T18:16:30.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Record history now shows a new revision (v3.4.2) and removes the previous revision (v3.4.1), updating the revision sequence for this study.
    Difference
    0.0%
    Check dated 2026-02-13T13:28:34.000Z thumbnail image
  9. Check
    110 days ago
    Change Detected
    Summary
    The page history shows the addition of revision v3.4.1 and the removal of revision v3.4.0. This is a minor metadata update to the site's revision records and does not affect trial data or core content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:20:51.000Z thumbnail image

Stay in the know with updates to Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib & Trastuzumab in HER2+ Solid Tumors Clinical Trial page.